Spectrum Pharmaceuticals
SPPI
$1.03
Share price
0.00%
Change (1 day)
17.05%
Change (1 year)
Categories
Operating Margin for Spectrum Pharmaceuticals (SPPI)
Operating Margin as of April 2024 (TTM): -109.76%
According to Spectrum Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -109.76%. At the end of 2018 the company had an Operating Margin of -109.77%.
Operating Margin history for Spectrum Pharmaceuticals from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2018 | -109.77% | 30.43% |
| 2017 | -84.15% | 74% |
| 2016 | -48.36% | 56.05% |
| 2015 | -30.99% | 33.01% |
| 2014 | -23.30% | -0.88% |
| 2013 | -23.51% | -179.68% |
| 2012 | 29.50% | 9.02% |
| 2011 | 27.06% | -141.03% |
| 2010 | -65.96% | 26.86% |
| 2009 | -51.99% | 3.22% |
| 2008 | -50.37% | -89.61% |
| 2007 | -484.81% | 6.22% |
| 2006 | -456.43% | -85.87% |
| 2005 | -3,231.02% | -34.87% |
| 2004 | -4,961.24% | 381.44% |
| 2003 | -1,030.50% | 69.03% |
| 2002 | -609.67% | -99.11% |
| 2001 | -68,469.52% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -120.85% | 🇺🇸 USA |
 Novartis NVS | 17.27% | -115.73% | 🇨🇭 Switzerland |
 Pfizer PFE | 34.61% | -131.53% | 🇺🇸 USA |
 Abbott Laboratories ABT | 15.60% | -114.21% | 🇺🇸 USA |
 Biogen BIIB | 31.30% | -128.52% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 19.24% | -117.53% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 22.54% | -120.54% | 🇬🇧 UK |
 Seagen
SGEN | -30.69% | -72.04% | 🇺🇸 USA |
 Curis CRIS | -426.66% | 288.72% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -20.53% | -81.30% | 🇮🇱 Israel |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.